Company / Inventory
Pfizer Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$10.7B
FY2025
5-year range
$9.0B / $10.9B
FY2021-FY2025
Trend
-1.8%
vs FY2024
Sector context
#3 of 105
Health Care
What the data says
Among 105 Health Care companies, Pfizer is in the top 3% for inventory. Inventory has fluctuated over the past 10 years, ranging from $6.8B in FY2016 to $10.9B in FY2024.
Based on SEC 10-K filings.
$10.7B in FY2025 with a 5-year CAGR of +5.8%. Ranks 3rd among 105 companies in Health Care.
Improved from $10.2B to $10.7B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +5.9%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 105This company $10.7B Sector average $885.3M
▼
+1103.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, inventory decreased 1.8% year-over-year.
- Ranks #3 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.7B | -1.8% |
| FY2024 | $10.9B | +6.5% |
| FY2023 | $10.2B | +13.5% |
| FY2022 | $9.0B | -0.9% |
| FY2021 | $9.1B | +13.0% |
| FY2020 | $8.0B | +13.5% |
| FY2019 | $7.1B | -6.6% |
| FY2018 | $7.6B | -0.1% |
| FY2017 | $7.6B | +11.7% |
| FY2016 | $6.8B | -9.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026